MDedge Rheumatology » Rheumatoid Arthritis
1 FOLLOWERS
The following section of MDedge Rheumatology deals with Rheumatoid Arthritis. MDedge Rheumatology and Rheumatology News are the leading independent news site and newspapers for practicing rheumatologists. Readers rely on MDedge Rheumatology for breaking news, on-site medical meeting coverage, and insightful commentary that can be used daily in practice.
MDedge Rheumatology » Rheumatoid Arthritis
1y ago
The median time from ILD diagnosis to onset of AE was 48.5 months ..read more
MDedge Rheumatology » Rheumatoid Arthritis
1y ago
The rate of stopping azathioprine due to hematopoietic toxicity was nearly three-fold higher in patients with the CC genotype ..read more
MDedge Rheumatology » Rheumatoid Arthritis
1y ago
Hydroxychloroquine initiation in older patients with rheumatoid arthritis and a history of heart failure was associated with an increased risk of ..read more
MDedge Rheumatology » Rheumatoid Arthritis
1y ago
Physicians fear that women won’t get the best treatments or will face dangerous risks ..read more
MDedge Rheumatology » Rheumatoid Arthritis
1y ago
Retrospective data hint at antitumor activity, but other explanations are possible ..read more
MDedge Rheumatology » Rheumatoid Arthritis
1y ago
Developing depression after a diagnosis of rheumatoid arthritis substantially increased the risk for death over 10 years in a large Danish ..read more
MDedge Rheumatology » Rheumatoid Arthritis
2y ago
Contrary to ACR guidance, EULAR recommends starting methotrexate and glucocorticoids but dose reduction and discontinuation is emphasized ..read more
MDedge Rheumatology » Rheumatoid Arthritis
2y ago
Short-term methotrexate used in patients with arthralgia sustainably reduces disease burden and MRI-detected inflammation in all at-risk groups ..read more
MDedge Rheumatology » Rheumatoid Arthritis
2y ago
Artificial intelligence may improve early diagnosis of interstitial lung disease ..read more
MDedge Rheumatology » Rheumatoid Arthritis
2y ago
Phase 3 trial results of baricitinib in juvenile idiopathic arthritis (JIA) show the JAK inhibitor increases time to flare and reduces frequency ..read more